Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2742- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
New York University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2016 - 2024
TX State Medical License 2007 - 2017
Clinical Trials
- MM CAR-T to Upgrade Response BMTCTN1902 Start of enrollment: 2022 Jan 05
Roles: Contact
Publications & Presentations
PubMed
- Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.Malek, A., Al-Juhaishi, T., Milton, D., Ramdial, J., Daher, M., Olson, A., Srour, S., Alatrash, G., Oran, B., Mehta, R., Khouri, I., Bashir, Q., Shah, N., Ciurea, S., ...> ;Bone Marrow Transplantation. 2024 Feb 14
- Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancer.Lena Chaitesipaseut, Thach-Giao Truong, Fang Niu, Patrick Shin, Kavita Sharma, Joshua Smith, Rita L Hui, Shah, N.> ;Journal of Oncology Pharmacy Practice. 2023 Nov 21
- 2 citationsRandomized phase 2 study of digital life coaching during transplantation for myeloma.Rahul Banerjee, Chiung-Yu Huang, Chloe Ryan, Albert Lee, Kelly J Brassil, Jasmine Moore, Shagun Arora, Alfred Chung, Sandy W Wong, Jeffrey Wolf, Thomas Martin, Anand D...> ;Bone Marrow Transplantation. 2023 Dec 1
- Join now to see all
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
Abstracts/Posters
- Germline Variation Predicts Treatment Response in Multiple MyelomaNina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and _Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and BiologyNina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cord Blood Regulatory T Cells Prevent Mutiple Myeloma Progression By Suppressing InflammationNina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in C...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Immunotherapy in Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Daratumumab (DARA) Plus Lenalidomide Versus Lenalidomide Alone As Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma (NDMM) after Frontline Autolo...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
- CAR T-cell Therapy Produces Deep, Sustained Remissions in Patients with Relapsed MyelomaFebruary 24th, 2021
- Dr. Shah Discusses Data on Ide-Cel and Melflufen, Both Granted Priority Review by FDAOctober 23rd, 2020
New Class of Drug Appears to Extend Survival in Patients with Triple-Refractory Multiple MyelomaJuly 30th, 2020- Join now to see all
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
